Rongtong Dictionary · Formula

Liuwei Dihuang Pill: From the 'Transformation' of Jinkui Kidney-Qi Pill and the Three-Tonify-Three-Drain Design to Modern Diabetes Cohort Research

Published and reviewed 2026-07-09

Liuwei Dihuang (Six-Ingredient Rehmannia) Pill comes from the Song pediatric master Qian Yi's Xiao'er Yaozheng Zhijue, originally named simply 'Rehmannia Pill' and devised for the 'five delays' of congenital insufficiency in children. It was created by removing cinnamon twig and aconite from Zhang Zhongjing's kidney-qi pill, converting a 'warm the kidney yang' formula into a 'nourish the kidney yin' one — a celebrated act of formula transformation. Its six ingredients form the rigorous 'three-tonify-three-drain, tonify over drain' structure that later ages honored as the ancestral yin-nourishing formula and the mother of the rehmannia-pill lineage; modern large-cohort diabetes research now re-examines its role, though 'kidney yin deficiency' remains a traditional construct, never a modern diagnosis.

Origin: how a pediatric formula became the ancestral yin tonic

Liuwei Dihuang Pill comes from the Northern Song pediatric master Qian Yi (c. 1032-1113) and his Xiao'er Yaozheng Zhijue (compiled by his disciple Yan Xiaozhong). It did not begin as a kidney tonic; its original name was simply 'Rehmannia Pill,' devised for the 'five delays' of congenital insufficiency in children (delayed standing, walking, hair, teeth, and speech) and for signs such as fontanelles that fail to close and dispirited weakness — presentations read as liver-kidney yin deficiency. Because so many formulas were named after rehmannia and confusion was easy, later physicians renamed it 'Six-Ingredient Rehmannia Pill' after its six components.

Its birth was a famous act of subtraction. Its 'ancestor' is the kidney-qi pill of Zhang Zhongjing's Jinkui Yaolue (eight-ingredient, adding cinnamon twig and aconite to the six), for a kidney yin-and-yang deficiency with lumbar pain, lower-abdominal tension, and inhibited urination. Judging children's constitution unsuited to warm, drying agents, Qian Yi removed the yang-warming cinnamon twig and aconite, turning a 'warm the kidney yang' formula toward 'nourish the kidney yin' — a 'remove two, reverse the direction' change later ages called a transformation, making the pill the representative and 'ancestral' yin-nourishing formula. This page identifies the entity only and offers no dose conversion or administration procedure.

Composition: the three-tonify-three-drain paradigm

Six ingredients: prepared rehmannia (Rehmanniae Radix Praeparata, sovereign), cornus (Corni Fructus, minister), Chinese yam (Dioscoreae Rhizoma, minister), alisma (Alismatis Rhizoma, assistant), moutan bark (Moutan Cortex, assistant), and poria (Poria, assistant). The classical proportions — rehmannia eight qian, cornus and yam four qian each, alisma, moutan, and poria three qian each — with 'tonifying herbs heavier than draining ones' are the essence of the design.

'Three-tonify-three-drain' is the formula's most famous paradigm: rehmannia nourishes yin, tonifies the kidney, and fills essence as sovereign; cornus supplements the liver and kidney and astringes essence, and yam fortifies the spleen and secures the kidney, together as ministers — the three 'tonify' the liver, spleen, and kidney yin. Alisma percolates damp and offsets rehmannia's cloying richness; moutan clears deficiency (ministerial) fire and tempers cornus's warm astringency; poria percolates spleen damp and aids yam's transport — the three are the 'drain,' all assistants. Wang Ang's Yifang Jijie praised it as 'treating all six channels yet specific to kidney and liver, unbiased in cold and dryness, tonifying both qi and blood.' The whole 'drains within tonifying, tonifies primarily,' and since rehmannia equals cornus plus yam in dose, it tonifies all three yins with the kidney foremost — this 'open-and-close, unblocking tonification' is why it transcends ordinary tonics as a paradigm of formula compatibility.

Pattern, not disease: 'kidney yin deficiency' is not a modern diagnosis

The textbook mechanism is 'liver-kidney yin deficiency.' The kidney stores essence and governs bone and marrow; when kidney yin is depleted there is aching in the lower back and knees, dizziness and tinnitus, steaming-bone tidal fever, night sweats and seminal emission, hot palms and soles, dry mouth and throat, a red tongue with scant coating, and a thin rapid pulse. The method is 'nourish yin and tonify the kidney, clearing deficiency heat.'

Here 'kidney,' 'kidney yin,' and 'deficiency (ministerial) fire' are traditional functional constructs — the 'kidney' is not the anatomical kidney, and 'kidney yin deficiency' is not a synonym for chronic kidney disease, diabetes, menopausal syndrome, or any modern diagnosis. Popular use treats the pill as a 'kidney-strengthening, virility' supplement suitable for everyone, a double error: first, it nourishes kidney yin, not yang (yang tonification belongs to the kidney-qi line), so yang-deficient users are ill-served; second, 'tonifying the kidney' first requires confirming a genuine kidney-yin-deficiency pattern — weak digestion, phlegm-damp, damp-heat, or the non-deficient do not qualify. Similar symptoms do not imply the same pattern, which is the key to why the pill must not be taken as a blind self-tonic.

A mother formula and the rehmannia-pill family

The pill's stature comes from its role as the mother of a whole 'rehmannia-pill family.' Adding anemarrhena and phellodendron yields Zhibai Dihuang Pill (nourish yin, drain fire, for yin-deficiency fire with steaming-bone fever); adding wolfberry and chrysanthemum yields Qiju Dihuang Pill (nourish kidney and liver, for blurred, dry eyes of liver-kidney yin deficiency); adding schisandra yields Qiwei Duqi Pill (nourish the kidney and grasp qi, for deficiency wheezing); adding ophiopogon as well yields Maiwei Dihuang Pill (nourish the kidney and astringe the lung, for lung-kidney yin-deficiency cough). Ming physician Zhang Jingyue's Jingyue Quanshu removed the 'three drains' and added wolfberry, achyranthes, cuscuta, deer-antler glue, and tortoise-shell glue to make the purely tonifying Zuogui Pill for true-yin deficiency.

From the eight-ingredient kidney-qi pill to Liuwei Dihuang, then to Zuogui and Yougui pills and the Zhibai, Qiju, and Maiwei formulas, a clear 'kidney-tonifying' evolutionary lineage takes shape: adjusting the tonify-drain ratio by adding or removing the 'three drains,' or adding heat-clearing, eye-brightening, lung-astringing, and qi-grasping agents to extend the pattern scope. This 'one formula as pivot, modified by pattern into a system' evolution makes Liuwei Dihuang the core pivot for understanding the entire kidney-tonifying method and the logic of tonify-drain compatibility, and commentators' repeated exposition of its 'three-tonify-three-drain, tonify over drain' has made it one of the most-cited teaching examples in formula studies.

Active constituents: from polysaccharides and glycosides to drug-metabolism cautions

In modern terms, the material basis decomposes into each herb's actives: rehmannia's catalpol and polysaccharides, cornus's loganin and iridoids, yam polysaccharides, alisma's alisol triterpenes, moutan's paeonol, and poria's polysaccharides and triterpenes. Animal and cell studies report antioxidant, immunomodulatory, and glucose-lipid-metabolism activity; an obese-rat study, for instance, found that the formula lowered body weight and improved insulin and leptin sensitivity, giving its 'yin-nourishing' experience a metabolic footnote.

Modern pharmacology also flags a possible effect on drug-metabolizing enzymes — rehmannia-based formulas may alter the activity of some hepatic enzymes (such as the cytochrome P450 family), potentially changing the metabolism and blood levels of co-administered Western drugs. This matters especially for chronic-disease patients: many who take Liuwei Dihuang are already on long-term hypoglycemic or antihypertensive drugs, and altered metabolism could change efficacy or safety. The caveat stands: such work is largely in-vitro, animal, and network-pharmacology prediction — mechanistic exploration, not human proof, and certainly not a basis for self-combining drugs.

Evidence: what a large diabetes cohort study shows

The pill has relatively rare large-population evidence. A Taiwan National Health Insurance Research Database case-control/cohort study (2021) enrolled 70,036 type-2-diabetes patients and found that traditional-medicine users had a lower risk of insulin use than non-users (HR 0.58, 95% CI 0.56-0.60), and among traditional-medicine users, Liuwei Dihuang users had a further-reduced risk versus users of other traditional medicine (HR 0.86, 95% CI 0.82-0.90), with a dose-dependent relationship. The authors' conclusion was cautious: use of the pill together with oral hypoglycemics is 'highly associated' with delayed insulin use, and clinicians 'may take it into consideration.'

This study is an excellent case for the limits of 'association evidence.' First, it is an observational cohort, not a randomized trial — association is not causation, and confounders such as healthy-user bias may operate. Second, the intervention was 'the pill combined with oral hypoglycemics,' not the pill alone, so the finding cannot be extrapolated to 'monotherapy treats diabetes' or 'replaces hypoglycemics.' Third, 'delayed insulin use' is a specific outcome, not 'cure' or 'improvement of all measures.' The defensible statement is that a dose-dependent association with a specific outcome was observed in a specific combination-therapy population with limited certainty — not that the pill is proven to treat diabetes.

Quality standards, patent medicines, and the Western-drug context

Rehmannia, cornus, yam, alisma, moutan, and poria are all Chinese Pharmacopoeia (2020) materials with identity and assay markers (cornus by loganin, moutan by paeonol). Liuwei Dihuang Pill itself is a Pharmacopoeia-listed classic patent medicine, available as large honeyed pills, water-honeyed pills, concentrated pills, granules, and oral liquid, alongside the Zhibai, Qiju, Maiwei, and other 'rehmannia-pill' series; but same-named or series products differ markedly in ratio, form, and process and in functional positioning, and are not interchangeable — using Qiju Dihuang Pill (biased toward nourishing the liver and brightening the eyes) as Liuwei Dihuang is a misuse.

As contextual overlap (relationship only, not an efficacy comparison): the pill's modern research settings (type 2 diabetes, chronic kidney disease populations) correspond at the Western-drug level to categories such as oral hypoglycemics, insulin, and kidney-disease drugs. This is adjacency of research population only, never equivalence of constituents or efficacy; and as noted, rehmannia-based formulas may affect drug-metabolizing enzymes, so co-use with these long-term drugs must be assessed by professionals for interactions rather than self-layered.

Safety boundaries: 'tonifying the kidney' requires differentiation most of all

Although an over-the-counter yin tonic, the pill is not suitable for everyone. Its rich, cloying components such as rehmannia may burden the stomach and foster damp, so weak digestion, poor appetite with loose stool, copious phlegm, damp exuberance, or diarrhea are unsuited; those without a kidney-yin-deficiency pattern (kidney yang deficiency, repletion, or the non-deficient) may worsen on misuse. Package inserts state clearly that patients with serious chronic disease — hypertension, cardiac disease, liver disease, diabetes, kidney disease — and children, pregnant, and breastfeeding women should use it under medical guidance.

More importantly, given the drug-metabolism caution above, those on long-term hypoglycemic or antihypertensive drugs should have combination assessed professionally first. Aching lower back and knees, dizziness and tinnitus, and tidal fever with night sweats have many causes, and when persistent should be worked up medically rather than self-treated long-term under the banner of 'tonifying the kidney.' The pill is an excellent model for tonify-drain compatibility and the wisdom of formula transformation, but the premise of its 'tonifying' is always differentiation.

A checklist for reading any formula article

1. Composition and preparation: does a stated effect come from Liuwei Dihuang itself, or from the Zhibai/Qiju/Maiwei series? Is the form a pill, granule, or decoction? These must not be conflated.
2. Pattern versus disease: has 'kidney yin deficiency' been swapped for diabetes, chronic kidney disease, or menopausal syndrome, and has 'nourish kidney yin' been confused with 'tonify kidney yang'?
3. Evidence tier: does the conclusion rest on an observational cohort (association is not causation), an animal model, or an RCT — and on monotherapy or combination with Western drugs?
4. Safety and interactions: are the cloying-burden limits, the drug-metabolism interaction with long-term drugs, and 'yin-tonifying requires differentiation' addressed?
5. Dose and procedure: responsible education identifies the entity and stops short of individual dosing and modifications — chronic-disease patients combining it should consult a physician and pharmacist.

Educational and academic reference only. It does not provide a diagnosis, prescription, dosage, or treatment recommendation. Yin-tonification requires differentiation, and rehmannia-based formulas may affect drug metabolism and interact with long-term drugs. Persistent lower-back and knee aching or tidal fever with night sweats should be medically evaluated for cause; chronic-disease patients should consult a licensed physician and pharmacist before combining.